<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Leeuwen, D. van</title>
    <link>http://repub.eur.nl/res/aut/8813/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/8159/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>Granulocyte colony-stimulating factor (G-CSF) is the major regulator of
      neutrophil production. Studies in cell lines have established that
      conserved tyrosines Tyr704, Tyr729, Tyr744, Tyr764 within the cytoplasmic
      domain of G-CSF receptor (G-CSF-R) contribute significantly to
      G-CSF-induced proliferation, differentiation, and cell survival. However,
      it is unclear whether these tyrosines are equally important under more
      physiologic conditions. Here, we investigated how individual G-CSF-R
      tyrosines affect G-CSF responses of primary myeloid progenitors. We
      generated G-CSF-R-deficient mice and transduced their bone marrow cells
      with tyrosine "null" mutant (m0), single tyrosine "add-back" mutants, or
      wild-type (WT) receptors. G-CSF-induced responses were determined in
      primary colony assays, serial replatings, and suspension cultures. We show
      that removal of all tyrosines had no major influence on primary colony
      growth. However, adding back Tyr764 strongly enhanced proliferative
      responses, which was reverted by inhibition of ERK activity. Tyr729, which
      we found to be associated with the suppressor of cytokine signaling,
      SOCS3, had a negative effect on colony formation. After repetitive
      replatings, the clonogenic capacities of cells expressing m0 gradually
      dropped compared with WT. The presence of Tyr729, but also Tyr704 and
      Tyr744, both involved in activation of signal transducer and activator of
      transcription 3 (STAT3), further reduced replating efficiencies.
      Conversely, Tyr764 greatly elevated the clonogenic abilities of myeloid
      progenitors, resulting in a more than 10(4)-fold increase of
      colony-forming cells over m0 after the fifth replating. These findings
      suggest that tyrosines in the cytoplasmic domain of G-CSF-R, although
      dispensable for G-CSF-induced colony growth, recruit signaling mechanisms
      that regulate the maintenance and outgrowth of myeloid progenitor cells</description>
    </item> <item>
      <title>Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment (Article)</title>
      <link>http://repub.eur.nl/res/pub/9151/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Severe congenital neutropenia (SCN) is a heterogeneous condition
          characterized by a drastic reduction in circulating neutrophils and a
          maturation arrest of myeloid progenitor cells in the bone marrow. Usually
          this condition can be successfully treated with granulocyte
          colony-stimulating factor (G-CSF). Here we describe the identification of
          a novel point mutation in the extracellular domain of the G-CSF receptor
          (G-CSF-R) in an SCN patient who failed to respond to G-CSF treatment. When
          this mutant G-CSF-R was expressed in myeloid cells, it was defective in
          both proliferation and survival signaling. This correlated with diminished
          activation of the receptor complex as determined by signal transducer and
          activator of transcription (STAT) activation, although activation of STAT5
          was more affected than STAT3. Interestingly, the mutant receptor showed
          normal affinity for ligand, but a reduced number of ligand binding sites
          compared with the wild-type receptor. This suggests that the mutation in
          the extracellular domain affects ligand-receptor complex formation with
          severe consequences for intracellular signal transduction. Together these
          data add to our understanding of the mechanisms of cytokine receptor
          signaling, emphasize the role of GCSFR mutations in the etiology of SCN,
          and implicate such mutations in G-CSF hyporesponsiveness.</description>
    </item>
  </channel>
</rss>